China's top drug regulator said it approved Merck & Co.'s Molnupiravir for emergency use on Thursday. "China Approves Merck's Molnupiravir for Emergency Use, Regulator Says," at 0809 GMT, incorrectly said the approval came on Wednesday.

(END) Dow Jones Newswires

December 30, 2022 03:52 ET (08:52 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merck Charts.